GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.100
-0.110 (-4.98%)
At close: Jun 2, 2026, 4:00 PM EDT
2.080
-0.020 (-0.95%)
Pre-market: Jun 3, 2026, 5:16 AM EDT
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $6.07 million as of June 2, 2026. Its market cap has decreased by -59.40% in one year.
Market Cap
6.07M
Enterprise Value
5.20M
1-Year Change
-59.40%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $6.07M, an increase of 2,432.26%. That is a compound annual growth rate of 61.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 6.07M | -17.29% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 6.99M |
| Alaunos Therapeutics | 6.95M |
| Processa Pharmaceuticals | 6.73M |
| Purple Biotech | 6.56M |
| Cardio Diagnostics Holdings | 6.30M |
| Aptevo Therapeutics | 6.19M |
| SciSparc | 6.07M |
| FibroBiologics | 6.05M |